you are viewing a single comment's thread.
My Group. Dr Lesley move moved things up on our timetable.
pierre, open your eyes watching EXEL,
IT IS GOING TO SPIKE WITH TAKEOVER DEAL. EXEL HAS 30 drug candidate in the level of preclinical trial to phase III clinical trials. EXEL is on good cash position. so EXEL is one of the best take over candidate.
Sentiment: Strong Buy